27404 membres inscrits Accès abonné revues  Aide   Newsletter    Me connecter
Les Communiqués
     Nasdaq OMX
Rechercher dans le flux Nasdaq OMX
Pihlajalinna Oyj :Pihlajalinna's financial reporting in 2016
Wed, 07 10 2015 09:00:00
Pihlajalinna Oyj STOCK EXCHANGE RELEASE 7.10.2015 at 12.00 (EET) Pihlajalinna's financial reporting in 2016 Pihlajalinna will publish its financial information in 2016 as follows: (...)
BK Ultrasound, Powered by Analogic, Launches bk5000 Ultrasound System Designed for Surgery
Tue, 06 10 2015 18:31:14
Premium System Offers Superb Image Quality, Simplicity and Speed PEABODY, Mass., Oct. 06, 2015 (GLOBE NEWSWIRE) --  Analogic Corporation  (Nasdaq:ALOG), enabling the world's medical imaging and aviation security technology, (...)
Medtronic to Unveil New Clinical Data for its Innovative Portfolio of Interventional Technologies at TCT 2015
Tue, 06 10 2015 16:30:00
Meeting Highlights New Two-Year Data on IN.PACT Admiral DCB, First Report of Real-World TVT Registry with CoreValve System, First One-Year Data on Recapturable Evolut R, and Initial Results on First Implants of Drug-Filled Stent (...)
Active Biotech's partner Teva presents data on laquinimod for the treatment of multiple sclerosis at 31st ECTRIMS Congress
Tue, 06 10 2015 12:00:00
Lund, October 6, 2015 - Active Biotech (NASDAQ STOCKHOLM: ACTI) today announces that the collaboration partner Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) will present data on laquinimod, an investigational therapy being (...)
Adaptimmune Announces New Research and Development Facility in Oxfordshire
Tue, 06 10 2015 11:00:00
'Enterprise Zone' Building Will House Company's Expanding R&D Operation OXFORD, UK and PHILADELPHIA, Oct. 06, 2015 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), ("Adaptimmune" or the (...)
Affimed to Present Data on Potency of NK- and T-cell EGFRvIII TandAbs at SITC
Tue, 06 10 2015 09:00:00
Heidelberg, Germany, Oct 6th, 2015 - Affimed N.V. (Nasdaq: AFMD), a clinical-stage biopharmaceutical company developing highly targeted cancer immunotherapies, today announced that the Company's abstract has been chosen for a poster (...)
Molecular Health to Offer Early Access Program for SafetyMAP(TM)
Mon, 05 10 2015 17:39:09
Enrollment Now Open for Early Access Program (EAP) Set to Launch in November 2015 CAMBRIDGE, Mass., Oct. 5, 2015 (GLOBE NEWSWIRE) -- Molecular Health, a leader in cloud-based healthcare decision support technology to optimize the selection of (...)
Medtronic's Valiant® Thoracic Stent Graft System Demonstrates Durability After Five Years
Mon, 05 10 2015 13:00:00
Valor II U.S. Study Shows Strong Safety and Efficacy in Treatment of Thoracic Aortic Aneurysms DUBLIN and Newport, R.I. - October 5, 2015 - Medtronic plc ( NYSE:MDT ) today announced favorable five-year (...)
Dako, an Agilent Technologies Company, Announces FDA Approval of New Companion Diagnostic for Lung Cancer
Mon, 05 10 2015 06:00:00
Validated Assay Offers New Option for Patients GLOSTRUP, Denmark, Oct. 5, 2015 - Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, announced Oct. 2 that the U.S. Food and Drug Administration (...)
Mon, 05 10 2015 05:35:39
Global Bioenergies secures a line of equity financing with Société Générale Evry, 5 October 2015 - Global Bioenergies (Alternext Paris: ALGBE/eligible for PEA-PME) announces the implementation of an optional line of (...)
Mon, 05 10 2015 05:35:39
Global Bioenergies sécurise une ligne de financement en fonds propres avec Société Générale Evry, le 5 octobre 2015   - Global Bioenergies (Alternext Paris : ALGBE / éligible PEA-PME) annonce la mise en place (...)
Alcon receives FDA Approval for pre-loaded intraocular lens delivery system to treat patients undergoing cataract surgery
Mon, 05 10 2015 05:15:00
AcrySof ® IQ Aspheric Intraocular Lens (IOL) with UltraSert TM Pre-loaded Delivery System helps maintain integrity of incision while facilitating smooth IOL delivery   (...)
Pihlajalinna Oyj:Pihlajalinna expands social services area to asylum seeker reception center operations
Mon, 05 10 2015 05:00:00
Pihlajalinna Oyj STOCK EXCHANGE October 5, 2015, at 8.00 (EET) Pihlajalinna expands social services area to asylum seeker reception center operations Finnish Immigration Service has asked for urgent help from the private social and (...)
Galapagos raises ?1.2 million through warrant exercises
Fri, 02 10 2015 20:01:00
Mechelen, Belgium; 2 October 2015 - Galapagos NV (Euronext & NASDAQ: GLPG) announced a share capital increase arising from warrant exercises.  As a result of warrant exercises, Galapagos issued 118,260 new ordinary shares on (...)
Medtronic Completes Acquisition of Twelve, Inc.
Fri, 02 10 2015 18:12:48
DUBLIN - October 2, 2015 - Medtronic plc (NYSE: MDT) today announced that it has completed the acquisition of Twelve, Inc. ("Twelve"), a privately-held medical device company based in Redwood City, CA, focused on the (...)
Celyad participe au Large and Midcap Event à Paris
Fri, 02 10 2015 17:04:39
Mont-Saint-Guibert, Belgique - Celyad (Euronext Brussels et Paris, et NASDAQ: CYAD), entreprise leader dans la découverte et le développement de thérapies cellulaires annonce sa participation à la 15ème édition de l'European Large & (...)
Celyad participating in Large and Midcap Event in Paris
Fri, 02 10 2015 17:04:39
Mont-Saint-Guibert, Belgium - Celyad (Euronext Brussels and Paris, and NASDAQ: CYAD), a leader in the discovery and development of engineered cell therapies, announces its participation in the 15th  edition of the European Large & Midcap (...)
Augmentation de capital : Interview vidéo André Kérisit Pdg I.CERAM
Fri, 02 10 2015 06:21:26
COMMUNIQUÉ Paris, le 2 octobre 2015 I.CERAM, société spécialisée dans la conception, la fabrication, et la commercialisation d'implants orthopédiques innovants en biocéramique, a lancé son augmentation de capital sur (...)
I.Ceram : Lance son augmentation de capital sur Alternext Paris
Fri, 02 10 2015 06:00:00
Communiqué de presse                                                                                                              Limoges, 2 octobre 2015 I.CERAM lance son augmentation de capital sur Alternext (...)
FDA accepts Sandoz regulatory submission for a proposed biosimilar etanercept
Fri, 02 10 2015 05:15:00
Etanercept is an anti-TNF medicine used to treat a range of immunological diseases including rheumatoid arthritis and psoriasis. Sandoz is seeking approval for all indications included in the reference (...)
Novavax Announces Management Promotion
Thu, 01 10 2015 20:30:00
GAITHERSBURG, Md., Oct. 01, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that (...)
Weifa ASA : Dividend payment date on 6 October 2015
Thu, 01 10 2015 13:30:21
Reference is made to announcements of 25 September 2015 and 28 September 2015 concerning the NOK 0.09 per share dividend approved by Weifa's shareholders meeting on 25 September 2015. The dividend will be paid to the shareholders on 6 October (...)
Apricus Biosciences and Ferring Pharmaceuticals Sign Exclusive Distribution Agreement to Market Topical Erectile Dysfunction Cream Vitaros(TM) in Latin American Countries
Thu, 01 10 2015 11:00:00
Apricus Eligible to Receive Up to $18.25 Million in Upfront and Milestone Payments, in Addition to Royalties on Net Sales SAN DIEGO, Oct. 1, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company (...)
Ekso Bionics Hires Senior Medical Device Executive for Europe, Middle East, Africa (EMEA) Markets
Thu, 01 10 2015 10:00:00
Ruediger Hausherr Joins Team as President in Europe; Strategically Builds Team  RICHMOND, Calif., Oct. 1, 2015 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today (...)
Lumenis Introduces the New Pulse(TM) 100H and Pulse(TM) 50H Holmium Laser Systems* Designed to Treat Any Size of Prostate and Any Size and Type of Stone
Thu, 01 10 2015 08:00:00
Expanding Its Comprehensive Urology Portfolio, Lumenis Debuts Two Innovative Laser Systems for the Treatment of BPH and Stones LONDON, Oct. 1, 2015 (GLOBE NEWSWIRE) -- Lumenis Ltd. (NASDAQ:LMNS), the world's largest energy-based (...)

Afficher toutes les thématiques